Fig. 3From: Unveiling novel inhibitors of dopamine transporter via in silico drug design, molecular docking, and bioavailability predictions as potential antischizophrenic agentsPanels a and b are 2D and 3D interactions of the compounds 39g and 39m between the target protein while panel c is the docking pose of compound 39g showing hydrogen bonding and hydrophobic interactions between the proteinBack to article page